Heart Failure
Conditions
Interventions
Experimental group:Hydrogen inhalation + conventional therapy
Control group:oxygen inhalation + conventional therapy
Sponsors
Taian Central Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 110 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for HF of the Cardiovascular Disease Branch of the Chinese Medical Association; 2. New York Heart Association (NYHA) cardiac function class II-III.
Exclusion criteria
Exclusion criteria: 1. Patients with severe liver and kidney insufficiency, malignant tumors, and severe infections; 2. Patients with severe hypoxemia requiring high-flow oxygen inhalation or mechanical ventilation; 3. Patients who take antibacterial drugs and anti-inflammatory drugs irregularly; 4. Patients with involuntary activities, unconsciousness, severe mental illness history, and alcoholism; 5. Patients who are participating in interventional clinical research; 6. Patients considered by the investigator to be unsuitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin 6;Tumor necrosis factor alpha, TNF-a;Hypersensitive C-reactive protein;Superoxide dismutase;Nitric oxide;N-terminal B-type natriuretic peptide; | — |
Secondary
| Measure | Time frame |
|---|---|
| Echocardiography; | — |
Countries
China
Contacts
Public ContactZhang Hanbing
Taian Central Hospital
Outcome results
None listed